Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Clinical trial NCT01473758 · TERMINATED
Trial details
- NCT number
- NCT01473758
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-03-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.